Multiple-dose Peak Time
Multiple-Dose Peak Time is a pharmacokinetic metric that denotes the time at which the maximum plasma concentration is achieved following the administration of multiple doses of a drug, distinguishing it from single-dose peak time by accounting for accumulation and steady-state pharmacokinetics.
8
Publications
365
Citations
47
Authors
21
Institutions
Publications per year
2017–2026
0
Variants
Multiple-dose Tmax
Parents
8
Walter Krauwinkel, Jan van Dijk, Marloes Schaddelee et al. · Clinical Therapeutics · 2012 · 96 citations
Accumulation Pharmacokinetics of Tobramycin
Jerome J. Schentag, George Lasezkay, Thomas J. Cumbo et al. · Antimicrobial Agents and Chemotherapy · 1978 · 67 citations · Full text
Seong Ryul Kim, Tomoko Hasunuma, Osamu Satō et al. · Cardiovascular Drugs and Therapy · 2011 · 54 citations
1–5 of 8
47
2
h-index
2
h-index
University of Massachusetts Chan Medical School, United States
1 publications · 54 citations
1
h-index
1
h-index
1
h-index
1–5 of 47
21
Massachusetts General Hospital
Boston, United States
2 h-index
4 publications
156 citations
Otsuka (Japan)
Tokyo, Japan
1 h-index
4 publications
216 citations

Massachusetts Mental Health Center
Boston, United States
1 h-index
2 publications
84 citations
Pauls Stradiņš Clinical University Hospital
Riga, Latvia
1 h-index
3 publications
57 citations
University at Buffalo, State University of New York
Buffalo, United States
1 h-index
5 publications
335 citations
Hammersmith Medicines Research
London, United Kingdom
1 h-index
1 publications
19 citations
Astellas Pharma (Netherlands)
Leiden, Netherlands
1 h-index
6 publications
576 citations
Kitasato Institute Hospital
Tokyo, Japan
1 h-index
1 publications
54 citations
1–8 of 21
1 publications · 19 citations
1
h-index
AAC · 1 publications · 67 citations
1
h-index
IR · 1 publications · 16 citations
1
h-index
1 publications · 35 citations
1
h-index
1 publications · 42 citations
1
h-index
1–5